India’s drug regulator has directed pharmaceutical manufacturers and importers to submit Periodic Safety Update Reports (PSURs) for new drugs from the date the product is actually marketed, rather than ...
With the patent expiry of Lilly and Novo’s weight-loss drugs in India on March 20, at least six generic drugmakers have already launched their versions, intensifying competition in the ...
U.S. President Donald Trump gestures as he makes an announcement about lowering the cost of drug prices, at the Roosevelt Room of the White House in Washington | Photo ...
Budget 2024: As Finance Minister Nirmala Sitharaman presents Union Budget for record-seventh time in coming month, India's pharmaceutical companies are hoping for tax incentives and financial assistance for research ...